Infection prevention specialist, GAMA Healthcare, has appointed industry leader and GlaxoSmithKline (GSK) veteran, Dr Teresa Layer, as science and innovation director.
Dr Layer will bring 22 years of corporate healthcare experience to the role, during which time she helped lead the successful development of the Sensodyne toothpaste brand from a small acquisition to a £1.2 billion household name. Most recently, Dr Layer held the position of vice-president of oral health category research and development.
The top-tier appointment of Dr Layer will help build on the success of GAMA Healthcare’s infection prevention products in the UK and further afield.
Commenting, GAMA co-founder Dr Guy Braverman, said: “We’re delighted to be welcoming someone of Teresa’s calibre to GAMA to build on the legacy of Dr Adrian Fellows. We have exciting plans for the future and Teresa will play a crucial role in taking our products forward.”
Dr Layer added: “I’m delighted to be joining GAMA at such an exciting time for the company. GAMA are right at the coalface of the fight against AMR, and expanding at huge pace internationally. I look forward to being part of the team”.
